LCM
SUPN icon

Landscape Capital Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Landscape Capital Management’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-9,512
Closed -$300K – 814
2025
Q2 		$300K Buy
+9,512
New +$305K 0.02% 534
2018
Q1 		– Sell
-16,614
Closed -$662K – 660
2017
Q4 		$662K Buy
+16,614
New +$657K 0.06% 323
2015
Q4 		– Sell
-29,200
Closed -$410K – 1043
2015
Q3 		$410K Sell
29,200
-1,739
-6% -$32.3K 0.06% 379
2015
Q2 		$525K Buy
+30,939
New +$440K 0.09% 314

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Landscape Capital Management's SUPN Position: Q3 2025 in Review

Landscape Capital Management sold out of Supernus Pharmaceuticals (SUPN) in Q3 2025, closing a stake of 9,512 shares — an estimated $300K sold.

Landscape Capital Management first reported a position in SUPN in Q2 2015 and held it in 4 quarters. The position peaked at $662K in Q4 2017. 310 funds tracked by Wall St. Rank hold SUPN as of Q3 2025.

  • Landscape Capital Management reported no remaining Supernus Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Landscape Capital Management sold 9,512 Supernus Pharmaceuticals shares in Q3 2025, an estimated $300K.
  • Landscape Capital Management first reported a position in Supernus Pharmaceuticals in Q2 2015 and held it in 4 quarters.
  • Landscape Capital Management's Supernus Pharmaceuticals position peaked at $662K in Q4 2017.
  • 310 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q3 2025.

Based on Landscape Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.